QC Kinetix has rapidly emerged as a leading regenerative medicine provider, offering patients advanced, non-invasive options for joint pain and discomfort relief. Since its inception in 2017, the company has made significant strides, expanding to over 100 cities nationwide and serving thousands with its innovative therapies.
The company utilizes regenerative treatments to harness the body’s natural healing capabilities, improving function and offering relief from musculoskeletal pain without resorting to surgery.
In May 2024, Entrepreneur magazine ranked QC Kinetix among the top 10 New and Emerging Franchises of the year. The company rose to the 9th position, attributed to its rapid unit growth, financial robustness, and strong brand influence.
Over the past three years, QC Kinetix has achieved a remarkable unit growth rate of 2,111%, positioning it among the most successful brands in its sector.
“We’re honored to rank among some of the fastest-growing franchise brands,” the CEO of QC Kinetix expressed. “The recognition is a true testament to our entire team’s hard work and dedication. I’m excited to watch our brand continue to grow and push the boundaries of what’s possible in the regenerative medicine industry.”
QC Kinetix is supported by leading figures in the industry.
The company’s fundamental goal is to deliver patients an advanced alternative for effective pain management. QC is fueled by a strong commitment to improving people’s lives, enabling them to regain their quality of life without relying on medications, surgery, or steroids. Thousands of patients have benefitted from their innovative biologics treatment protocols, underscoring their dedication to patient care. The company recently appointed renowned orthopedic surgeon Dr. Mitchell Sheinkop as the national medical director of QC Kinetix.
Dr. Sheinkop ushers in a new era for the company, bringing over 37 years of expertise in joint replacement surgery.
His decision to join QC Kinetix reflects his confidence in the transformative potential of regenerative medicine and his dedication to enhancing patient care.
In his position, Dr. Sheinkop will oversee the medical management team, concentrating on evaluating and refining treatment protocols while spearheading research and development initiatives to keep the franchise at the forefront of medical innovation. He also aims to incorporate physical therapy and weight management into existing treatment plans, enhancing patient outcomes and satisfaction, and ultimately strengthening the brand’s overall impact.
With Dr. Sheinkop at the helm, QC Kinetix is poised to enter an exciting new era. His vast experience combines exceptional clinical skills with a commitment to education and professional development, making him an ideal leader to propel QC Kinetix toward greater innovation and success.
The company also enjoys support from notable sports figures, including Pro Football Hall of Famer Emmitt Smith, who acts as QC Kinetix’s national spokesperson.
“I’ve got to keep taking care of these joints,” Smith remarked, “no losing for this guy. When I take QC Kinetix natural supplements, it’s like – bam – Emmitt 2.0. Sometimes, you need a competitive edge.”
An Introduction to QC Kinetix
The story begins with a convergence of professionals—a medical doctor, a physician assistant, a nurse practitioner, and a business expert—coming together with a shared vision.
In search of a name that would pay homage to their Charlotte, North Carolina roots, famously dubbed “the Queen City” (QC), they found the first element of their brand identity.
The term Kinetix draws inspiration from kinetic energy, epitomizing movement and activity. The mission of QC Kinetix is to help individuals regain mobility through the regenerative capabilities of their own cells.
The founders of QC Kinetix saw a profound chance to revolutionize the conventional approaches to musculoskeletal pain. Their vision was to create a pioneering, safer, and more effective strategy using a concierge medical model that employs regenerative medicine to enhance patients’ lives. This innovative spirit distinguishes QC Kinetix and fuels its ongoing quest to advance the field of regenerative medicine.
Many patients experience debilitating pain that hinders their ability to partake in cherished activities like golf, climbing stairs, or playing with grandchildren. QC Kinetix provides an exceptional treatment alternative that eschews the use of damaging drugs, toxic steroid injections, and surgery’s inherent risks.
“No longer did we want insurance to tell us what they were willing to pay to treat a patient,” explained a company spokesperson. “We wanted the research to tell us the most effective method, whether it was covered by insurance or not, and bring it to the United States in a very transparent and patient-focused manner. QC Kinetix is an opportunity to become the first option when dealing with pain, not the alternative to those ways. That is our mission over time.”
Patient-Focused Treatment Methods at QC Kinetix
QC Kinetix stands at the forefront of regenerative medicine, enabling individuals to sustain their active lifestyles by leveraging advanced regenerative treatments to manage musculoskeletal and joint discomfort.
Their innovative biologics treatment protocols have provided relief to thousands of patients.
The approach at QC Kinetix involves utilizing the body’s inherent healing abilities through cutting-edge natural biologic treatments, offering an alternative to invasive surgeries and dependency-inducing pain medications.
The clinics prioritize stimulating the body’s natural healing and repair processes, leading to significant improvements in functionality and overall quality of life.
Patients often seek treatment for pain in areas such as the knees, shoulders, or hips. At QC Kinetix, treatments capitalize on the body’s regenerative capabilities to restore health. Since its founding, the company has reached numerous important milestones.
By 2023, QC Kinetix reached a landmark with over $100 million in system-wide sales, and in April 2024, they celebrated serving their 40,000th patient since the start of their nationwide expansion in 2021.
“It is our goal to change medicine,” stated the CEO of QC Kinetix. “We want to be the first thing people think about when they or a loved one are dealing with pain. We measure that success by seeing feedback from our patients that we could change their lives. We aim to care for our patients and employees first, knowing that growth and profit will follow.”
QC Kinetix Close to Achieving a Groundbreaking Advance
QC Kinetix, already well-established in the United States, is now eyeing expansion into international markets. The company has plans to venture into the United Kingdom, Australia, and New Zealand in the upcoming years, aiming to strengthen its global presence in regenerative medicine.
The company has set an ambitious target of opening 250 locations across the United States by the end of 2024.
This rapid expansion marks a significant achievement over just four years of franchising. Despite this fast growth, the CEO of QC Kinetix expressed that the only surprising aspect is that the expansion hasn’t happened even quickly, given the high demand for alternatives to pain medications and surgical procedures. This growth underscores the robust demand for non-surgical options for pain relief and the keen interest from franchise investors and operators in the healthcare field.
“I love this brand and our future,” the CEO of QC Kinetix expressed. “It’s about impacting people’s lives and being a game-changer in the medical field.”
